Validation studies of outcome measures in pemphigus

Area of Science:

• Autoimmune diseases
• Dermatology
• Clinical trial methodology

Background:

• Pemphigus is a rare, severe autoimmune blistering disease.
• No cure exists despite therapeutic advancements.
• Lack of standardized, validated pemphigus severity measures hinders research.

Purpose of the Study:

• To evaluate existing pemphigus severity outcome measures.
• To identify the most reliable and valid instruments for clinical trials.
• To highlight the need for responsiveness analysis in outcome measure validation.

Main Methods:

• Review of over 116 pemphigus severity outcome measures.
• Comparative analysis of the Pemphigus Disease Area Index (PDAI), Autoimmune Bullous Skin Disorder Intensity Score (ABSIS), and Pemphigus Vulgaris Activity Score (PVAS).
• Assessment based on validity and reliability criteria (COSMIN standards).

Main Results:

• PDAI demonstrated superior validity and reliability compared to ABSIS and PVAS.
• ABSIS showed higher reliability than PVAS.
• PVAS indicated potentially greater validity, though results were inconsistent.

Conclusions:

• PDAI, ABSIS, and PVAS are the most corroborated pemphigus severity measures.
• Responsiveness analysis is crucial for complete validation of these instruments.
• Standardized, validated measures are essential for advancing pemphigus research and treatment.